← Evidence map

ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2022

Regulatory Evaluation of Biosimilars: Refinement of Principles Based on the Scientific Evidence and Clinical Experience.

Pekka Kurki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35596890